GlassScriptPhysician profile
Allan A Dias
NPI 1639355142
$5,141.10
in general payments reported to CMS, 2019-2025
11 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $106 · 2021: $112 · 2022: $56.77 · 2023: $4,656 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,635 · Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,635.00 |
| Food and Beverage | $121.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,658.47 | 2019-2023 | Ofev |
| Covis Pharma Gmbh | $153.52 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $90.81 | 2019-2022 | |
| Fisher & Paykel Healthcare INC | $78.53 | 2025 | Fisher & Paykel Healthcare |
| Glaxosmithkline, LLC. | $56.89 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $21.97 | 2025 | Dupixent |
| Vapotherm INC | $21.60 | 2022 | |
| Baxter Healthcare | $20.63 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Sobi, INC | $17.38 | 2020 | |
| Philips North America LLC | $13.21 | 2020 | |
| Ambu INC. | $8.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Dias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.